is metformin glp-1 RA initiation versus and risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation Comparing Glucagon‐like peptide‐1 receptor agonists

We surveyed 250 GLP-1 users to uncover their emotional, physical, and lifestyle challenges through firsthand accounts

Beyond their hypoglycemic and metabolic effects, GLP-1based therapies have demonstrated anti-inflammatory effects, with in vitro and in vivo accumulating evidence demonstrating that GLP-1 reduces levels of inflammatory markers [[30], [31], [32]]

We are committed to offering personalized care aimed at improving your overall health and well-being

Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications

Practical Considerations for Taking Empagliflozin Empagliflozin, a leading medication for type 2 diabetes, requires attention to detail in terms of dosing, administration, and lifestyle considerations to ensure effectiveness and safety

While effective, semaglutides benefits are largely driven by reduced caloric intake, with modest effects on energy expenditure